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Abstract 
Investigating the function of combining induced rat monocytes-derived bone marrow-haemopoietic 
stem cell (rat BM-HSCs) with LPS and rat bone marrow-mesenchymal stem cell (rat BM-MSCs) was 
to analyze the acceleration of homing process mechanism in injured pancreas. Mononucleated 
stem cells were isolated from aspirated whole rat BM using ficoll and cultured in α-MEM complete 
growth medium in 10 cm petridish. After two days, adherent cells after washing twice in petridish 
were added α-MEM growth medium and then mesenchymal cells were characterized using CD105 
marker in third passage and labeled PKH26. Then haemopoietic stem cells (HSCs) were isolated 
with magnetic beads CD34+ and differentiated in vitro, and then induced monocytes with LPS. 
Animal experiment used 28 male Wistar rats, and divided them into 4 groups. After transplanta-
tion combined, both cells between monocyte derived HSc (mHSCs) and rat BM-MSC were analyzed 
expression of pair box gen 4 (Pax4), pancreatic and duodenal homeobox (Pdx1), C-peptide using 
immunohistochemistry, then secretion of insulin and C-peptide analyzed using in-direct ELISA. 
Results showed that the expressions of Pax4, Pdx1, C-peptide found in the surface membrane cell 
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of pancreatic cell, and secreted C-peptide and insulin were shown significant (P < 0.05) in trans-
planted group 2, 3 and 4, but in group 3 were transplanted with combined cells more dominant 
than non-combined cells. Conclusions suggested that combining of induced monocytes-derived 
HSCs and rat BM-MSCs has accelerated homing MSCs into injured pancreatic tissue. 
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1. Introduction 
The role of MSCs in the modulation of the immune response, immune system activity, and the body’s response 
to inflammation and disease has been widely studied for many years, but homing mechanisms are still limited. 
MSCs both rely upon and co-create a network that facilitates constant communication between normal and 
damaged cells in the body [1]. MSCs might be metaphorically compared to a signaling system that has been ex-
tensively studied but remains not fully understood. In particular, the factors that trigger MSC responses and the 
tools required for MSCs to respond in a positive way to a particular insult to the body remain largely unknown. 
To effectively fight the fires in our bodies, an adequate supply of MSCs with high potential is needed to, meta-
phorically, act as firefighters. Properly culture-expanded and engineered MSCs with enhanced homing capabili-
ty can ensure removal of the damaged cells and increase the rate of regeneration when the balance is disrupted in 
the body [2] [3]. A variety of strategies have been suggested to enhance the homing of MSCs based on their 
well-known characteristics [4]. On the other hand, the acute phase of injury, factors released from damaged tis-
sues recruit blood cells and MSCs to repair the injured site. In this regard, substantial evidence indicates that in-
fused MSCs have higher engraftment efficiencies within sites of inflammation or injury. Also it is demonstrated 
that inflammatory stimuli of allergic rhinitis induced the homing of intravenously administered hAdMSCs to 
cell-damaged areas. The evidences indicate that signals are required to recruit MSCs with high efficiency, which 
is critical for improving the clinical benefits of MSCs [5]. 
In this study, the acceleration of homing mechanism using induced monocytes-derived HSCs CD34+ in in-
jured pancreas was analyzed, because activated monocytes can express many kinds of molecule signaling like 
CRCX4 and TNF-α that can induce migration of rat BM-MSCs to the injured area. Monocyte chemo-attractant 
(MCP)-1 is typically expressed at sites of inflammation and can thus represent a model homing chemokine, be-
cause MSCs have expressed the MCP-1 receptor and chemokine receptor (CCR) 2 on the cell surface membrane 
cell [6]. 
Multiple approaches are now being investigated to generate insulin-producing cells in vitro either by genetic 
engineering of β-cells or by utilizing various β-cell precursor cells and stem/progenitor cells with the ability to 
grow in vitro and to differentiate into insulin-producing cells and ultimately into β-cells [7]. The demonstration 
of plasticity of mesenchymal stem cell has been published and has led to their study in the treatment of diabetes 
[8]. In diabetics, 90% of insulin-secreting β-cells of the pancreatic islets of Langerhans are destroyed. Some in-
vestigators has demonstrated that insulin secreting cells (β-cells or otherwise) could be transplanted into patients 
to help maintain blood glucose homeostasis, reduce the burden of diabetes-related complications, overcome the 
limitation of donor organs and provide benefit to millions of diabetics, and thus the replacement of insu-
lin-secreting β-cells would be an ideal cure [8]. Studies of the growth, development and differentiation of bone- 
marrow mesenchymal stem cell (BM-MSCs) have been explored as a new clinically relevant cell type to repair 
injured tissue, and they can modulate immune response going to up-regulation and down-regulation like in the 
sepsis cases or ischemia. But the mechanism of accelerating homing modulation in injured tissue is still unclear. 
This research was to find the model of acceleration of homing mechanism that interacted between ligands and 
receptors of mesenchymal and monocytes-derived HSCs like chemo-attractant. 
2. Materials and Methods 
2.1. Animal Experiment 
This experiment used male Wistar rats, weight 200 gram and age 3 mounths were obtained from Veterenary 
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Farma, Surabaya, Indonesia who that undergoverment instituton has produced for vet vaccine, diagnostic and 
has breeding of some kinds animals laboratory. Four groups of 28 Wistar rats, first group for control and each of 
second to fourth groups were treated using aloxan injection in dose of 50 mg/kg intraperitoneally according to 
method of Purwati [8], and then fasted for 72 h, and levels of C-peptide and insulin were measured by ELISA 
(Mercodia-Uppsala) to determine levels of β-islet pancreas damage. All animal experiments operation prosedure 
were conducted with institutional of ethics approval in accordance with Animal Care and Use Committee 
(ACUC) the Faculty of Veterinary Medicine, Airlangga University, Surabaya, Indonesia. Then research were de-
sign first group for control, second group were transplanted BM-MSCs, third group were transplanted mix cell of 
BM-MSCs and induced monocyte derived HSCs, fourth group were transplanted induced monocyte derived HSCs. 
2.2. MSCs Isolation and Culture of Rat Bone Marrow Stem Cell (BM-MSCs) 
Whole bone marrow were aspirated about 3 ml then isolated using Ficoll 0.077 density (Invitrogen). After cen-
trifugation by 1600 rpm, 30 min were isolated mononucleates cells from Buffy coat space and washed using 
growth medium serum free and followed centrifugation by 1600 rpm in 10 min. After that were cultured mono-
nucleate cells in petridish 10 cm and growing in complete medium (α-MEM) (Invitrogen) according to modified 
method of Wolf [9]. In third passage of mesenchymal stem cells phenotype were characterized immunotyphing 
of using marker CD150 and flow cytometry according to modified method of Omori [10], and then labeled used 
PKH26 (Sigma, USA). Total of MSCs 2 × 105 were mixed with induced monocyte derived HSCs using ratio 1:5 
for MSCs were used for transplanted to animal diabetic Mellitus. 
2.3. Immunocytochemistry 
This method was used to characterize of phenotype rat Bone-Marrow derived Mesenchymal Stem Cell (rBM- 
MSC) specific CD105 and CD34+. Cells were fixed in ice-cold methanol at –20˚C. Following two washes with 
PBS, the cells were blocked for 1 hour in PBS containing 1% bovine serum albumin (Sigma-Aldrich Corp) and 
0.1% Triton X-100 (Sigma-Aldrich Corp) for 45 min and then incubated in the primary antibody (CD105, 1:100, 
Dako) for 2 hour at room temperature. After three washes with PBS, the cells were incubated in secondary anti-
body (fluorescein isothiocyanat-conjugated antibodies rabbit anti rat-Dako) for 1 hour, and after final wash, the 
cells were imaged using an Olympus inverted fluorescent microscope. 
2.4. Flowcytometry 
Flow cytometric analysis for phenotype including isotype control, was performed according to manufactures. 
Freshly isolated cells were incubated for 15 min with erythrocyte lysis buffer at 41˚C then were cells washed 
with PBS, and incubated with Dil-ac-LDL (acLDL) (10 mg/ml) for 1 hour at 37˚C. Afterwards, cell were 
washed twice with plain medium, once with PBS, and fixed with 4% paraformaldehyde (PFA), and then cell 
were centrifuged at 1600 rpm for 10 men and resuspended in PBS containing 0.2% FCS and 2 mM EDTA. For 
incubation with primary anti rat CD105-FITC cell were also fixed with 4% PFA, resuspended in PBS containing 
0.2% FCS and 2 mM EDTA, and maintained at 41˚C for 30 min. After washing and incubation with secondary 
FITC-conjugate antibody was performed for 30 men at 41˚C with sample. Labeled cells were analyzed by flow-
cytometry according to the guide of BD (BD Biosciences, San Jose, CA) and cellQuest pro analysis. The per-
centage of positively stained cells was determined after correction for the percentage of cell reacting with the 
secondary FITC antibody. 
2.5. Isolation and Culture of Monocyte-Derived BM-Haemopoietic Stem Cell (BM-HSCs) 
Inducing LPS 
Whole rat bone marrows were isolated using CD34+ magnetic beads (Invitrogen). After centrifugation by 1600 
rpm in refrigerator centrifuge (Backman) was supernatant removed and resuspended in buffer elusion reagent 
(invitrogen) then repeated centrifugation by 1600 rpm at 15 min. After removing of supernatant were cells re-
suspended using complete medium α-MEM and plated in petridish, and for immunotyphing using flow cytome-
try according to modified method of Tarja and Sharkis [11], Rantam [12]. Then differentiated monocyte were 
induced with purified-lipopolysacharide (LPS-Institute of Tropical Disease Universitas Airlangga). Three days 
of induced Cells were harvested and counted by haemocytometer for preparing and combining with rat BM- 
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mesenchymal stem cell (BM-MSCs) through modified method of Belema-Bedada [6]. In these case were used 
ratio between rat BM-MSC and induced monocyte derived HSCs 1:5 for MSCs, then transplanted into DM-2 rat 
through intraperitoneally 2 × 105 of total cell according to modified method of Purwati [8]. 
2.6. Immunohistochemistry Analysis of Pancreatic Repair 
Cell sections of pancreatic tissue were fixed with 4% paraformaldehyde (Sigma) for 10 min. Immunohistoche-
mistry was performed as previously described by Shuang-zhi [13] and Purwati [8]. The cell sections were incu-
bated with rat monoclonal antibody anti-PDX-1 (1:200, Dako), anti-PAX-4 (1:200, Dako) and rat monoclonal an-
tibody anti C-peptide (1:200, Dako). The positive cells were examined and mounted under inverted microscope. 
2.7. Indirect ELISA 
Microplates (96-well, Nunc) were coated with rat sera from each group overnight at 4˚C, washed with PBS con-
taining Tween 20 (PBST) and blocked for 1 h at room temperature with 1% BSA. After three washes with PBST, 
the primary mAb anti C-peptide, insulin goat anti-rat were diluted appropriately in PBS 1:200 and incubated on 
the plates for 1 h at 37˚C. After three washes with PBST, horseradish peroxidase-conjugated anti-rat immunog-
lobulin was diluted in PBS 1:1500 and added to the wells. Following incubation for 45 min at 37˚C, the plates 
were washed three times with PBST, and ortho-phenylenediamine (OPD) substrate (Sigma) was added. The 
plates were incubated 10 min in the dark. After the addition of 1 M HCl, the plate was read on an ELISA reader 
(BioRad) with the 450 nm wavelength. This method was modified from Tanaka [14] and Owen and Robert [15]. 
2.8. Statistical Analysis 
Experimental data were presented as mean ± SD. Statistical calculations were performed using SPSS13.0 (SPSS 
Inc., USA). For statistical analyses, were used the Student’s t-test to compare data from normal donors with that 
obtained from injured pancreas and used a non-parametric test to compare the expression of pancreatic-specific 
markers. Statistical significance was defined as p < 0.05. 
3. Results and Discussion 
Rat bone marrow mesenchymal stem cells (rat BM-MSCs) were demonstrated previously by Purwati [8] for re-
pair of β pancreatic cell. To study the accelerated homing BM-MSCs were combined with induced monocyte 
derived HSCs, we first generated BM-MSCs and induced monocyte HSCs. Then analyzing of induced monocyte 
derived HSCs were demonstrated by expressing of TIR, MAC1, and CXCR4. Also the role of PDx1, Pax4 and 
C-peptide, insulin in injured pancreas. 
3.1. Phenotype Characterization of Mesenchymal Stem Cell CD105 and Haemopoietic 
Stem Cell CD34+ 
Bone marrow mesenchymal stem cell (BM-MSCs) has many kinds of markers like CD73, CD90, CD105 [16], 
in this study were used CD105 marker and in third passage were identified using specific markers surface mem-
brane cell anti CD150 labeled FITC. The results showed in Figure 1(d) about 89.1% were positive expressed 
CD150, also expressed CD34+ haemopoietic stem cell about 93.1% in Figure 2(c). 
In these cases have been enough of MSCs count expressed CD105, these results indicate homogeneity and 
viability of BM-MSCs high. Although this marker was used mostly for proliferation and differentiation cells in-
to osteoblast, chondroblast [12]. Expression of CD105 up to 80% on the surface membrane cells have important 
role, that mean were these cells already to mix with induced monocyte derived HSCs for transplantation, be-
cause it had showed an character of multipotent mesenchymal stem cell. 
The results showed in Figure 2(c), that count of mononucleate HSCs specific CD34+ about 93.1% three days 
cultured cells. These results indicated that HSCs have enough homogeny and already to induce with LPS. 
3.2. Induced Rat Monocyte Derive Haemopoietic Stem Cell (HSCs) 
The data in Figure 3 showed that induced monocyte derive HSCs expressed TIR and CXCR4 on the surface 
membrane cells. These indicate that monocyte derive HSCs have been good function to attracted of MSCs as  
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(a)                                                (b) 
    
 
89.1% 
R 
101 102 104 108  
(c)                                                (d) 
Figure 1. Analysis of bone marrow-mesenchymal stem cell (BM-MSCs) in third passage used CD105 marker surface mem-
brane MSCs. (a) Monolayer of rat BM-MSCs; (b) Single cell of trypsinated monolayer MSCs; (c) Phenotype expression spe-
cific CD105 on the surface membrane MSCs; (d) Percentage of CD 105 expression were analyzed by flow cytometry. ×40 
original magnifications. 
 
    
 
93.1% 
z 
101 102 104 108  
  (a)                                    (b)                                      (c) 
Figure 2. Rat bone marrow-haemopoietic stem cells (BM-HSCs). (a) Isolated HSCs of rat bone marrow using magnetic 
beads CD34+; (b) Three days of BM-HSCs cultured in complete medium α-MEM were determinate of phenotyphing using 
specific marker CD34+ labeled FITC and analyzed by immunocytochemstry and; (c) Flow cytometry (FAC scabulary-BD). 
×40 original magnification. 
 
once of migration factor during homing process. Although in generally showed that expression of CXCR4 rela-
tive highest 10% than TIR. 
3.3. Homing Process and PDX1-Pax4, and C-Peptide Expression 
Data in Figure 4 indicated that the healing process interacted with other molecule like chemokine, growth factor  
F. A. Rantam et al. 
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(a) 
   
(b)                                             (c) 
Figure 3. Analysis of protein expression in the surface membrane induced monocyte derived HSCs. (a) Diagram of expres-
sion toll interleukin receptor 1 (TIR-1), monocyte (MAC-1), chemokine receptor type-4 (CXCR4); (b) Differentiated mono-
cyte derive HSCs were detected with MAC-1 labelled FITC; (c) Differentiated monocyte derives HSCs as negative control. 
×40 original magnifications. 
 
    
(a)                       (b)                        (c)                        (d) 
Figure 4. Immunohistochemistry analysis of homing and activated β-islet cells in pancreatic diabetic rat group 1 and group 3, 
one week after transplanted mix cells of BM-MSCs and monocyte derive HSCs. (a) Normal rat pancreas were stained using 
rat anti-Pdx1; (b) Diabetic pancreatic rat were stained using rat anti-Pdx1, arrow showed Pdx1 expression; (c) Diabetic pan-
creatic rat were stained using rat anti-Pax4, arrow showed Pax4 expression; (d) Diabetic pancreatic rat were stained using rat 
anti C-peptide, arrow showed C-peptide expression. ×40 original magnifications. 
 
and extra cellular matric have most important role. Also expression of Pdx1, Pax4 and C-peptide have shown 
activated β islet cells as transcription factor had good function in the homing as early in healing mechanism. The 
others hand, the expression of C-peptide in injured pancreatic like Figure 5. Have shown relative lower then 
compared to group 3 (Figure 4). 
3.4. Discussion 
Mesenchymal stem cell (MSC) is multipotent stem cell, that has a plasticity properties, and also have many 
kinds of protein as markers or signal expressed on the surface membrane cell have important role in communi-
cation between cell. CD105 is relative stable markers of MSC, because many kinds of markers can be used for 
detection of MSCs like CD90, CD73 and cells did not express CD34, CD11b, CD19, CD45 and HLA-DR [17].  
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(a)                                               (b) 
Figure 5. Immunohistochemistry analysis of homing and activated β-islet cells in pancreatic di-
abetic rat, one week after transplanted from animal experiment group and group 4. (a) Rat injured 
pancreatic group 2, one week after transplanted BM-MSCs only reacted with anti C-peptide, arrow 
showed C-peptide expression; (b) Rat injured pancreatic group 4, one week after transplanted in-
duced monocyte derived HSCs only with anti C-peptide, arrow showed C-peptide expression. ×40 
original magnifications. 
 
The other hand, we used CD34+ for isolation of haemopoietic stem cell from bone marrow. Because this marker 
was stable for mononucleat haemopoietic stem cell, and also were differentiated into monocyte, and characte-
rized by monocyte (Mac1) markers. Induced monocyte derived HSCs (IM-HSCs) can express toll interleukine 
receptor (TIR) and CRCX4 like in Figure 3, this way it can be used as a chemotractant for accelerating of MSCs 
homing. 
BM-MSCs have many kind of ligands expression and also IM-HSCs have many kinds of receptors with dif-
ferent function, but they were influenced high by microenvironment. This way the stem cell can derived into 
different type of desire cell. In this research, we used rat BM-MSCs with expression of CD105 positive 81.3% in 
Figure 1(d) and HSCs expressed CD34 positive 91.3% in Figure 2(c). The results showed that combining of 
MSCs and induced monocytes HSCs more better modulated to repair in injured pancreas than BM-MSCs and 
IM-HSCs only. 
The primary goal of this study was to determine of the accelerated homing function by combining BM-MSCs 
and IM-HSCs, and characterized by expression of Pax4, Pdx1, and C-peptide on the surface membrane pancrea-
tic cells. 
Combining MSC and monocytes HSCs transplantation can increase activation of homing process than without 
combining stem cell. Other indicators showed TIR as signaling molecule, CXCR4 as adhesion molecule were 
increasing. The other meaning that both molecule especially monocytes HSCs can induce stem cells migration 
and adhesion into injured tissue. In order for MSCs to provide a pleiotropic immunomodulatory effect that is 
responsive to different stimulants such as cytokines and chemokines and targets different effectors cells such as 
T-cells, NK-cell and DCs, it seems reasonable for MSCs to employ both by direct and soluble mediators that 
coordinate for a multi-pronged approach to therapy [8]. 
Pax4 is positioned in the upper hierarchy among the β-cell transcription factors, and its expression in β-cell 
precursors results in the differentiation and maturation of β-cell. The results in Figure 4 showed expression of 
Pax4, that mean pax4 as the first step to activated β-cell in injured pancreatic tissue. Because by inactivating of 
Pax4 in newborn Pax4 deficient mice, pancreases are almost entirely devoid of mature β-cell [18]. In vitro study 
have been reported that Pax4 over expression in mouse embryonic stem cells increases insulin-producing cells 
dramatically as compared to Pdx1 [19]. These suggesting Pax4 have important role in the healing process of in-
jured pancreas. 
Pdx1 expression like in Figure 4(b) showed that Pdx1 expressed co-populations of cells in injured pancreas, 
which possibility came from combined mix cell after transplantation to induce transdifferentiation into insulin 
producing cells. Pdx1 is transcription factor molecule can converts the hepatic-like cells into pancreatic precur-
sor cells. Because it is this factor necessary for pancreatic development and β-cell maturation. The precursor 
cells can respond to glucose [18]. This way it was more important as markers to identify of precursor cells as 
transcription factor. Pdx1 appears to also play role in the fating of endocrine cells, encoding for insulin and so-
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matostatin, two pancreatic endocrine products, while repressing glucagon. Pdx1 pancreatic progenitor cell also 
co-express Nkx6-1, and these progenitor cell form the initial pancreatic buds, which further proliferate and 
branch in responses to FGF-10 signaling [20]. 
C-peptide is produced by a series of enzymatic cleavage of the precursor molecule preproinsulin and proinsu-
lin. Preproinsulin is a precursor of proinsulin, is produced in the endoplasmic reticulum of pancreatic β-cell in 
respon to elevated blood glucose levels [20]. In this study, the results like in Figure 6 showed expression 
C-peptide in population of pancreatic cells, but the secretion of C-peptide in serum significant p < 0.05. Table 1 
suggested that glucose and insulin became increasing, and indicated that β-cell islet was survival, and were in-
duced to switch in maturation of β-cell through paracrine effect of mesenchymal stem cell [21]. The capacity for 
self-renewal of post-natal murine β-cells have already study according to plasticity of MSCs [22], and also rat 
BM-MSCs has properties of the self renewal as multipotent stem cell. Through molecular and cellular pathways 
is highly likely. Endothelial signals have been linked with induction of pancreatic differentiation [23]. A 
dose-dependent effect has been noted [24], suggesting possible population expansion to be required prior to 
clinical transplantation. Finally, the demonstration of multi-step cell delivery being more efficient long-term [25] 
also underlines the possibility of introducing this principle in experimental and possibly clinical work. 
In this research, pancreatic cells were injured with alloxan and then pancreatic cell was releasing stromal de-
rived factor-1 (SDF-1). Alloxan would induce reactive oxygen species. The action of reactive oxygen species 
with a simultaneous massive increase in cytosolic calcium concentration causes rapid destruction of B cells [26]. 
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Figure 6. Secretion of C-peptide and insulin in serum, of all groups. Group 1: control healthy animal; Group 
2: rat transplanted with BM-MSCs; Group 3: rat transplanted with mix cell of BM-MSCs and IM-HSCs; 
Group 4: rat transplanted with IM-HSCs. Group of negative control showed lower content of C-peptide and 
also insulin than group 3. Group 4 showed lowest than other group 2, 3, and group 2 showed relative in mid-
dle content than others results. 
 
Table 1. Secretion of C-peptide and insulin content by rat injured pancreas, and one week after transplanted 
rat used BM-MSCs and induced monocyte HSCs (IM-HSCs). 
Type G1/plasebo G2/BM-MSCs G3/BM-MSCs and IM-HSCs G4/Induced Monocyte HSCs 
C-peptide ng/ml 1.02 ± 0.05 0.4 ± 0.01 1.00 ± 0.05* 0.30 ± 0.01 
Insulin ng/ml 0.49 ± 0.05 0.36 ± 0.05 0.42 ± 0.02* 0.20 ± 0.01 
*Statistical significance from serum rat injured pancreas after transplanted combined between BM-MSCs and IM-HSCs. 
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The chemokine SDF-1 are involved in cell migration, survival, and development of any cell types including he-
matopoeitic stem cells (HSC) and stromal stem cells (SSC) through CXCR4, during homeostasis CXCR4 highly 
expressed in HSC and low in SSC. In host defense and repair mechanism, SDF-1 and CXCR4 can recruitment 
of immature and maturing leukocytes from the bone marrow to damage organ like injured pancreatic cells. 
Homing stem cells in their niches regulate by the cross-talk between CXCR4 on hematopoietic cells and stromal 
cell-derived SDF-1 [27]. 
MSC have been shown to support hematopoiesis, it would be advantageous to co-transplant donor MSC with 
HSC to promote the rate of engraftment. Unfortunately, the transplant ability of marrow stromal elements re-
mains controversial, with most studies showing that MSC, or stromal cells, have a limited capacity to reconsti-
tute the marrow microenvironment. The fact that methods for isolation and amplification of MSC have been 
well studied and MSC home to BM with poor efficiency prompted us to find approaches to promote MSC hom-
ing and elucidate the mechanisms that guide homing of implanted MSC. Lately, CXCR4 was published to be 
expressed on the surface of MSC and BM stromal cells. The small proportion of MSC was expressed CXCR4, 
which contributed to their migration that capable of promoting migration to pancreatic islets in vitro. SDF-1 was 
reported could induce migration of human BM stromal cells in vitro and that CXCR4 might play a role in the 
engraftment of these cells in brain tissue of immunodeficient mice. 
In this experiment we demonstrate for the first time that enforced surface expression of CXCR4, TIR and 
MAC-1 by inducing CD34+ with LPS was able to enhance in vivo homing on pancreatic islet. CXCR4 is known 
to be up regulated when human MSC are exposed to cytokines, including insulin-like growth factor-1, which is 
present in cell culture serum. Several studies now report that human MSC migrate in vitro in response to SDF-1, 
perhaps mediated by up regulation of intracellular CXCR4 molecules [28]. MSC homing in pancreatic cells was 
indicated by expression of Pdx-1, Pax4, and C-peptide that more highly expressed than control. Expression of 
Pdx-1 can trigger transdifferentiation of β pancreatic cells to release insulin while expression of both Pax4 and 
C-peptide can induce both differentiation and maturation of β pancreatic cells. Another experiment has been re-
port that MSCs which do not express MAC-1, was also highly dependent on MAC-1 function [29]. MAC-1 ex-
pressing monocytes may induce MSC proliferation by an unknown mechanism. Outcome of CXCR4 signaling 
in some cells has been shown to be dependent on the concentration of SDF-1 [30]. Similar concentration-de- 
pendent mechanisms are emerging for effects of SDF-1 on activity of CD34 cells from different tissues. The 
chemokine SDF-1 plays a major role in migration, proliferation, differentiation, and survival of many cell types 
including human and murine hematopoietic stem/progenitor cells [31]. 
Beside MAC-1, LPS can induce hematopoietic stem cell expression of TIR/TLR4 through TRIF pathway [32]. 
MSC also express active TLR in various numbers depending on kind of source. TIR/TLR4 would trigger MSC 
for migration, proliferation and differentiation. Some groups have reported the effects of TLR activation on 
MSC differentiation with contradictory results [33]. Cell migration requires attachments to cells and matrix by 
adhesion molecules. Mac-1 is an adhesion molecule expressed by a variety of phagocytes including macrophag-
es in inflammatory sites bacterial lipopolysaccharide (LPS)-induced migration of macrophages out of inflamed 
tissues and into the lymph nodes [34]. 
4. Conclusion 
Homing stem cell can accelerate using combining between MSC and HSC. MSC has many kinds of molecular 
signaling or ligands on the cell surface, but monocytes HSC has many kinds of molecular ligands activated by 
cell and others cell to migration or interaction intracellular, and finally the cell can be easy to attachment to the 
other cell, then proliferation and differentiation and can integrate with host tissue. TIR and CCXR4 have an im-
portant role in homing process as attractants of MSCs. The accelerated mechanism of homing stem cell in in-
jured pancreatic was showed in Figure 7. Thus, further research is required to understand the factors affecting 
the efficiency of MSCs migration and to determine strategies to remove harmful factors and improve homing of 
MSCs to the area of injury. New approach could mean smaller quantities of MSCs necessary for infusion, the-
reby attaining the intended therapeutic goal with greatest efficiency and efficacy. To achieve this goal, cell mi-
gration and tracking studies must be conducted in various in-vivo environments along with in-vitro laboratory 
studies. Through these studies, optimized culture conditions can be established to cultivate MSCs with enhanced 
homing ability and express the appropriate homing receptor. This is also essential to improve vascular condi-
tions, so that introduced cells can easily migrate to damaged sites. 
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Figure 7. Mechanism of stem cell activity in injured pancreatic. 
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